Product Information
DESVENLAFAXINE SUCCNT ER 100 MG is a generic product labeled by Advagen Pharma Ltd., priced at $0.4136 per EA under NDC 72888014430. Its NADAC has been published 143 times since Jan 10, 2024.
FDA first approved this application on Jun 29, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888014430
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DESVENLAFAXINE SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA204028FDA Approved
6/29/2015
TE Code
AB
On Market Since
1/31/2022
Pharmacological Classes
Price Statistics
The NADAC for DESVENLAFAXINE SUCCNT ER 100 MG has been published 143 times since Jan 10, 2024, and over the history we have for it it has declined 20.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4136 per EA |
|---|---|
| All-time high | $0.5490 (Feb 14, 2024) |
| All-time low | $0.3558 (Nov 20, 2024) |
| 52-week high | $0.4475 |
| 52-week low | $0.4069 |
| Median price | $0.4455 |
| Average price | $0.4497 |
| Largest weekly change | +25.7% (Jun 19, 2024) |
| Weeks tracked | 143 |
| Tracking since | Jan 10, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Advagen Pharma Ltd. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DESVENLAFAXINE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin and Norepinephrine Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DESVENLAFAXINE SUCCNT ER 100 MG?
The current National Average Drug Acquisition Cost (NADAC) for DESVENLAFAXINE SUCCNT ER 100 MG, manufactured by Advagen Pharma Ltd., is $0.4136 per EA (NDC 72888014430), effective Sep 30, 2026.
How has the price of DESVENLAFAXINE SUCCNT ER 100 MG changed over time?
Over the history we have for it, the NADAC for DESVENLAFAXINE SUCCNT ER 100 MG has declined 20.0%. It has been tracked across 143 weekly CMS publications since Jan 10, 2024.
What are the highest and lowest recorded NADAC prices for DESVENLAFAXINE SUCCNT ER 100 MG?
Since Jan 10, 2024, the NADAC for DESVENLAFAXINE SUCCNT ER 100 MG has ranged from a low of $0.3558 (Nov 20, 2024) to a high of $0.5490 (Feb 14, 2024), with a median of $0.4455 per EA.
Are there cheaper alternatives to DESVENLAFAXINE SUCCNT ER 100 MG?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DESVENLAFAXINE SUCCNT ER 100 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures DESVENLAFAXINE SUCCNT ER 100 MG?
DESVENLAFAXINE SUCCNT ER 100 MG (NDC 72888014430) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.